Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997, 388: 300-304. 10.1038/40901.
Article
CAS
PubMed
Google Scholar
Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995, 83: 1243-1252. 10.1016/0092-8674(95)90149-3.
Article
CAS
PubMed
Google Scholar
Deveraux QL, Reed JC: IAP family proteins--suppressors of apoptosis. Genes Dev. 1999, 13: 239-252.
Article
CAS
PubMed
Google Scholar
Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997, 3: 917-921. 10.1038/nm0897-917.
Article
CAS
PubMed
Google Scholar
Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998, 396: 580-584. 10.1038/25141.
Article
CAS
PubMed
Google Scholar
Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K: Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene. 2000, 19: 1346-1353. 10.1038/sj.onc.1203429.
Article
CAS
PubMed
Google Scholar
Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S: Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 2002, 21: 2613-2622. 10.1038/sj.onc.1205353.
Article
CAS
PubMed
Google Scholar
Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F, Daidone MG: Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci. 2002, 59: 1406-1412. 10.1007/s00018-002-8518-3.
Article
CAS
PubMed
Google Scholar
Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD: Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999, 59: 6097-6102.
CAS
PubMed
Google Scholar
Schimmer AD: Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004, 64: 7183-7190. 10.1158/0008-5472.CAN-04-1918.
Article
CAS
PubMed
Google Scholar
Holcik M, Gibson H, Korneluk RG: XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 2001, 6: 253-261. 10.1023/A:1011379307472.
Article
CAS
PubMed
Google Scholar
Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J: Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol. 2001, 62: 13-19. 10.1016/S0006-2952(01)00632-3.
Article
CAS
PubMed
Google Scholar
Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, Tsuji M, Kami K, Miyatake S: Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg. 2003, 99: 738-745.
Article
CAS
PubMed
Google Scholar
Yang L, Cao Z, Yan H, Wood WC: Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 2003, 63: 6815-6824.
CAS
PubMed
Google Scholar
Nachmias B, Ashhab Y, Ben-Yehuda D: The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol. 2004, 14: 231-243. 10.1016/j.semcancer.2004.04.002.
Article
CAS
PubMed
Google Scholar
Liu SS, Tsang BK, Cheung AN, Xue WC, Cheng DK, Ng TY, Wong LC, Ngan HY: Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer. 2001, 37: 1104-1110. 10.1016/S0959-8049(01)00085-5.
Article
CAS
PubMed
Google Scholar
Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, Reed JC: cIAP1 Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res. 2005, 65: 210-218.
CAS
PubMed
Google Scholar
Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB: Characterization of XIAP-deficient mice. Mol Cell Biol. 2001, 21: 3604-3608. 10.1128/MCB.21.10.3604-3608.2001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Richmond A: Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol. 2002, 2: 664-674. 10.1038/nri887.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin ASJ: Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene. 2000, 19: 1123-1131. 10.1038/sj.onc.1203412.
Article
CAS
PubMed
Google Scholar
Holcik M, Gordon BW, Korneluk RG: The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol Cell Biol. 2003, 23: 280-288. 10.1128/MCB.23.1.280-288.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Altieri DC, Marchisio PC: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest. 1999, 79: 1327-1333.
CAS
PubMed
Google Scholar
Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998, 58: 5071-5074.
CAS
PubMed
Google Scholar
Kim HS, Shiraki K, Park SH: Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res. 2002, 22: 805-808.
CAS
PubMed
Google Scholar
Lee JP, Chang KH, Han JH, Ryu HS: Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. Int J Gynecol Cancer. 2005, 15: 113-119. 10.1111/j.1048-891X.2005.15011.x.
Article
PubMed
Google Scholar
Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Linehan R, Clynes M: Prognostic importance of survivin in breast cancer. Br J Cancer. 2003, 88: 1077-1083. 10.1038/sj.bjc.6600776.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakanishi K, Tominaga S, Hiroi S, Kawai T, Aida S, Kasamatsu H, Aurues T, Hayashi T, Ikeda T: Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Virchows Arch. 2002, 441: 559-563. 10.1007/s00428-002-0712-z.
Article
CAS
PubMed
Google Scholar
Kjaer SK, Brinton LA: Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev. 1993, 15: 486-498.
CAS
PubMed
Google Scholar
Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N, Duffy MJ: Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br J Cancer. 2005, 92: 120-124. 10.1038/sj.bjc.6602314.
Article
CAS
PubMed
Google Scholar
Meng H, Lu C, Mabuchi H, Tanigawa N: Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett. 2004, 216: 147-155. 10.1016/j.canlet.2003.12.020.
Article
CAS
PubMed
Google Scholar
Yoshida H, Sumi T, Hyun Y, Nakagawa E, Hattori K, Yasui T, Morimura M, Honda K, Nakatani T, Ishiko O: Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncol Rep. 2003, 10: 45-49.
CAS
PubMed
Google Scholar
Cao C, Mu Y, Hallahan DE, Lu B: XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene. 2004, 23: 7047-7052. 10.1038/sj.onc.1207929.
Article
CAS
PubMed
Google Scholar
Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y, Kobune M, Miyagishi M, Taira K, Tahara H, Hamada H: Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther. 2004, 10: 162-171. 10.1016/j.ymthe.2004.05.006.
Article
CAS
PubMed
Google Scholar
McEleny K, Coffey R, Morrissey C, Williamson K, Zangemeister-Wittke U, Fitzpatrick JM, Watson RW: An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis. Prostate. 2004, 59: 419-425. 10.1002/pros.10371.
Article
CAS
PubMed
Google Scholar
Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC: Rational design of shepherdin, a novel anticancer agent. Cancer Cell. 2005, 7: 457-468. 10.1016/j.ccr.2005.03.035.
Article
CAS
PubMed
Google Scholar
Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N: A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res. 2005, 11: 1474-1482. 10.1158/1078-0432.CCR-03-0817.
Article
CAS
PubMed
Google Scholar